Patents by Inventor Michael D. Rivard

Michael D. Rivard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of evaluating a test agent in a diseased cell model
    Patent number: 8298824
    Abstract: The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the tissues of the immune system in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates and other materials in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system, coupled with disease models to provide a more complete representation of an immune response.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: October 30, 2012
    Assignee: Sanofi Pasteur Vaxdesign Corporation
    Inventors: William L. Warren, Heather Fahlenkamp, Russell G. Higbee, Eric M. Mishkin, Guzman Sanchez-Schmitz, Michael D. Rivard, Santosh Pawar
  • METHODS OF EVALUATING A TEST AGENT IN A DISEASED CELL MODEL
    Publication number: 20120009561
    Abstract: The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the tissues of the immune system in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates and other materials in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system, coupled with disease models to provide a more complete representation of an immune response.
    Type: Application
    Filed: September 20, 2011
    Publication date: January 12, 2012
    Applicant: SANOFI PASTEUR VAXDESIGN CORP.
    Inventors: William L. WARREN, Heather FAHLENKAMP, Russell G. HIGBEE, Eric M. MISHKIN, Guzman SANCHEZ-SCHMITZ, Michael D. RIVARD, Santosh PAWAR
  • Methods of evaluating a test agent in a diseased cell model
    Patent number: 8062889
    Abstract: The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the tissues of the immune system in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates and other materials in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system, coupled with disease models to provide a more complete representation of an immune response.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: November 22, 2011
    Assignee: Sanofi Pasteur Vaxdesign Corp.
    Inventors: William L. Warren, Heather Fahlenkamp, Russel G. Higbee, Eric M. Mishkin, Guzman Sanchez-Schmitz, Michael D. Rivard, Santosh Pawar
  • METHODS OF EVALUATING A TEST AGENT IN A DISEASED CELL MODEL
    Publication number: 20100279277
    Abstract: The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the tissues of the immune system in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates and other materials in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system, coupled with disease models to provide a more complete representation of an immune response.
    Type: Application
    Filed: July 9, 2010
    Publication date: November 4, 2010
    Applicant: VAXDESIGN INC.
    Inventors: William L. WARREN, Heather FAHLENKAMP, Russell G. HIGBEE, Eric M. MISHKIN, Guzman SANCHEZ-SCHMITZ, Michael D. RIVARD, Santosh PAWAR
  • Disease model incorporation into an artificial immune system (AIS)
    Patent number: 7771999
    Abstract: The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the tissues of the immune system in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates and other materials in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system, coupled with disease models to provide a more complete representation of an immune response.
    Type: Grant
    Filed: March 12, 2008
    Date of Patent: August 10, 2010
    Assignee: VaxDesign Corp.
    Inventors: William L. Warren, Heather Fahlenkamp, Russell G. Higbee, Eric M. Mishkin, Guzman Sanchez-Schmitz, Michael D. Rivard, Santosh Pawar
  • DISEASE MODEL INCORPORATION INTO AN ARTIFICIAL IMMUNE SYSTEM (AIS)
    Publication number: 20090011455
    Abstract: The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the tissues of the immune system in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates and other materials in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interactions with the immune system, coupled with disease models to provide a more complete representation of an immune response.
    Type: Application
    Filed: March 12, 2008
    Publication date: January 8, 2009
    Inventors: William L. WARREN, Heather FAHLENKAMP, Russell G. HIGBEE, Eric M. MISHKIN, Guzman SANCHEZ-SCHMITZ, Michael D. RIVARD, Santosh PAWAR